HCW Biologics Inc. (HCWB)
Nasdaq: HCWB · Pharmaceutical Preparations · Miramar, FL · filing with the SEC since 2020
Who owns HCW Biologics Inc.
As filed with the SECHolders of 5% or more
1
Hing C. Wong, Ph.D. holds 23.4% of Common Stock, par value $0.0001 per share, as its SCHEDULE 13D/A filed Jun 13, 2025 says.
Directors and officers
4
report now, of 9 people on the record since 2021. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Hing C. Wong, Ph.D.
SCHEDULE 13D/A · filed Jun 13, 2025 · Common Stock, par value $0.0001 per share
Armistice Capital, LLC
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, par value $0.0001 per share · reported falling below 5%, from 9.99% in Feb 17, 2026
What HCWB reports owning in othersstakes of 5% or more, and other ties
HCW Biologics Inc. reports no stake in another company in the record.
Insider tradesForm 4
0sales
6purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$500,000bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window4 of 10 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Wong Hing C | Chief Executive Officer | 0 | $0 | 0 | 2 | $200,000 |
| Garrett Scott T | director | 0 | $0 | 0 | 2 | $300,000 |
| Byam Rebecca | Chief Financial Officer | 0 | $0 | 0 | 1 | $0 |
| Flowers Lee | SVP of Business Development | 0 | $0 | 0 | 1 | $0 |